Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spiridon Konitsiotis

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Behavioural Brain Research|April 20, 2006
Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon?Spiridon Konitsiotis, Christos Tsironis
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 20, 2025
Anti-Amyloid Agents: A Self-Fulfilling prophecyAlexandros Giannakis, Spiridon Konitsiotis
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 4, 2025
A new paradigm for neurodegenerative diseases classification: A clinical perspectiveAlexandros Giannakis, Spiridon Konitsiotis
Clinical Neurology and Neurosurgery|February 6, 2025
Increased incidence of akinetic crises in Parkinson's disease patients treated with Levodopa-Carbidopa Intestinal Gel: A case series and review of the literatureAlexandros Giannakis, Konstantinos Tsamis, Spiridon Konitsiotis
Expert Review of Neurotherapeutics|January 13, 2015
Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesiasPantelis Stathis, Spiridon Konitsiotis, Angelo Antonini
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 17, 2025
Diffusion Tensor Imaging in Progressive Supranuclear Palsy Versus Other Neurodegenerative Diseases: A ReviewAlexandros Giannakis, Spiridon Konitsiotis, Georgia Xiromerisiou
Medicina (Kaunas, Lithuania)|April 26, 2025
Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers-A Narrative ReviewAlexandros Giannakis, Spiridon Konitsiotis, Chrissa Sioka
Journal of Neural Transmission (Vienna, Austria : 1996)|May 30, 2025
A narrative review of serum biomarkers in progressive supranuclear palsy, corticobasal syndrome, and related disordersAlexandros Giannakis, Spiridon Konitsiotis, Chrissa Sioka
European Journal of Pharmacology|March 14, 2012
Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesiaSotirios Maranis, Dimitrios Stamatis, Christos Tsironis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
The course of dyskinesia induction by different treatment schedules of levodopa in Parkinsonian rats: is continuous dopaminergic stimulation necessary?Christos Tsironis, Marios Marselos, Angelos Evangelou, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Behavioural Brain Research|April 20, 2006
Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon?Spiridon Konitsiotis, Christos Tsironis
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 20, 2025
Anti-Amyloid Agents: A Self-Fulfilling prophecyAlexandros Giannakis, Spiridon Konitsiotis
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 4, 2025
A new paradigm for neurodegenerative diseases classification: A clinical perspectiveAlexandros Giannakis, Spiridon Konitsiotis
Clinical Neurology and Neurosurgery|February 6, 2025
Increased incidence of akinetic crises in Parkinson's disease patients treated with Levodopa-Carbidopa Intestinal Gel: A case series and review of the literatureAlexandros Giannakis, Konstantinos Tsamis, Spiridon Konitsiotis
Expert Review of Neurotherapeutics|January 13, 2015
Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesiasPantelis Stathis, Spiridon Konitsiotis, Angelo Antonini
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 17, 2025
Diffusion Tensor Imaging in Progressive Supranuclear Palsy Versus Other Neurodegenerative Diseases: A ReviewAlexandros Giannakis, Spiridon Konitsiotis, Georgia Xiromerisiou
Medicina (Kaunas, Lithuania)|April 26, 2025
Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers-A Narrative ReviewAlexandros Giannakis, Spiridon Konitsiotis, Chrissa Sioka
Journal of Neural Transmission (Vienna, Austria : 1996)|May 30, 2025
A narrative review of serum biomarkers in progressive supranuclear palsy, corticobasal syndrome, and related disordersAlexandros Giannakis, Spiridon Konitsiotis, Chrissa Sioka
European Journal of Pharmacology|March 14, 2012
Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesiaSotirios Maranis, Dimitrios Stamatis, Christos Tsironis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
The course of dyskinesia induction by different treatment schedules of levodopa in Parkinsonian rats: is continuous dopaminergic stimulation necessary?Christos Tsironis, Marios Marselos, Angelos Evangelou, et al.
Pageof 4